Search results
Results from the WOW.Com Content Network
Since November 2023, CRISPR Therapeutics has been earning approvals for Casgevy, a gene-editing medicine, in various countries and regions. This new coverage could also make it easier once CRISPR ...
Wake up with Breakfast news in your inbox every market day. Sign Up For Free » Recursion Pharmaceuticals (NASDAQ: RXRX) is a clinical-stage biotech that may have that level of potential.
The biotech also has a pair of other weight-loss programs, one in phase 1b trials and one that will soon start its phase 2b trials, both of which are similarly unique in terms of how they work.
The Biotechnology Innovation Organization (BIO), a Washington-based trade association representing biotechnology companies in the U.S. and more than 30 other countries, including WuXi AppTec, had ...
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
Recursion Pharmaceuticals is a clinical-stage biotechnology company that focuses on mapping and decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering. [1] [2] [3] The company is based in Salt Lake City, Utah. It was founded by Chris Gibson, Dean Li and Blake Borgeson. [4] [5]
A bill in the U.S. Congress that sparked a sell-off in shares of China's WuXi AppTec hit a delay in the Senate this week, a Senate aide and three other sources said on Friday. The bill would ...
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing.The company is headquartered in Cambridge, Massachusetts.